Learn more

MSN LABORATORIES PRIVATE LTD

Overview
  • Total Patents
    46
  • GoodIP Patent Rank
    35,857
  • Filing trend
    ⇩ 90.0%
About

MSN LABORATORIES PRIVATE LTD has a total of 46 patent applications. It decreased the IP activity by 90.0%. Its first patent ever was published in 2007. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and chemical engineering are SUZHOU FUSHILAI PHARMACEUTICAL CO LTD, HAINAN LINGKANG PHARMACEUTICAL and LEPETIT S A.

Patent filings per year

Chart showing MSN LABORATORIES PRIVATE LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Thirumalai Rajan Srinivasan 38
#2 Eswaraiah Sajja 32
#3 Rajesham Boge 10
#4 Venkat Reddy Ghojala 6
#5 Madhusudhan Gutta 6
#6 Satyanarayana Komati 5
#7 Sajja Eswaraiah 5
#8 Srinivasan Thirumalai Rajan 5
#9 Seetha Rama Sarma Peri 5
#10 Venkata Panakala Rao Gogulapati 4

Latest patents

Publication Filing date Title
US2019359606A1 Processes for the preparation of 7-{4-[4-(1-benzothiophen-4-yl) piperazin-1-yl]butoxy}quinolin-2(1h)-one
WO2017191650A1 Process for the preparation of 5-[[[(2s)-2-amino-3-[4-(aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1s)-1-(4-phenyl-1h-imidazol-2-yl)ethyl]amino]methyl-2-methoxybenzoic acid and its polymorphs thereof
WO2017163258A1 Process for the preparation of n-[6-(cis-2,6-dimethylmorpholin-4-yl)pyridine-3-yl]-2- methyl-4'-(trifiuoromethoxy) [1,1' -biphenyi]-3-carboxamide and its polymorphs thereof
WO2017158615A1 An improved process for the preparation of [[2(s)-[[4(r)-(3-hydroxy phenyl)-3(r), 4-dimethyl-1 -piperidinyl]methyl]-1 -oxo-3-phenylpropyl] amino]acetic acid dihydrate
WO2017154019A1 An improved process for the preparation of 1,3-bis(2-chloroethyl)-1-nitrosourea
WO2017154016A1 Novel crystalline polymorphs of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine hydrobromide and process for preparation thereof
WO2017149550A1 Amorphous form of 4-methyl-n-[3-(4-methyl-1h-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide
WO2017134679A1 Novel crystalline polymorphs of 4-[(2,4-dichloro-5-methoxvphenzl)amino] 6-methoxz-7-[3-(4-methyl-1-piperazinzl)propoxzl-3-quinolinecarbonitrile and process for preparation thereof
WO2017130217A1 The present invention relates to process for the preparation of d-glucitol, 1,5- anhydro-1-c-[4-chloro-3-[[4-[[(3s)-tetrahydro-3-furanyl] oxy]phenyl] methyl]phenyl]-, (1s) and its crystalline forms thereof.
WO2017098522A1 Crystalline polymorph of n-(2,2,2-trifluoroethyl-9-[4-[r4-r[[[i4'- (trifluoromethyl) [ 1,1 ' -biphenyl] -2-yl] carbonyl] amino] -1 -piperidinyl] butyl] -9h- fluorene-9-carboxamide methanesulfonate and process for preparation thereof
WO2017085734A1 Crystalline forms of tapentadol salts and process for preparation thereof
WO2017068596A1 An improved process for the preparation of (1s, 4s, 7z, 10s, 16e, 21r)- 7-ethylidene-4,21-bis(1-methylethyl)-2-oxa-12,13-dithia-5, 8, 20, 23- tetraazabicyclo[8.7.6]tricos-16-ene-3, 6, 9, 19, 22-pentone
US2019023655A1 Solid state forms of N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide and process for preparation thereof
WO2017025981A1 Process for the preparation of methyl 4,6-diamino-2-[l-(2-fhiorobenzvr)-lh-pyrazolo i3,4-blpvridin-3-vn-5-pyrimidinyl(methvl)carbamate and its polymorphs thereof
WO2017021975A1 Process for the preparation of crystalline forms of rifaximin
US2018186784A1 Crystalline forms of N-(2-chloro-6-methy]phenvn-2-[F6-[4-(2-hvdroxvethvl)-L-piperazin-vil-2-methvil-4-pvrimidinvllaminol-5-thiazolecarboxamide and their process thereof
US2018370982A1 Process for the preparation of [(1S,2R)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-carbamic acid (3R,3AS,6AR)hexahydro furo [2,3-B]furan-3-YL ester and its amorphous form
WO2016193997A2 Process for the preparation of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid and pharmaceutically acceptable salts thereof
US2018297989A1 Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereof
WO2016170545A1 Process for the preparation of 1-[(3r)-3-[4-amino-3-(4-phenoxyphenvl)-1h- pvrazolo[3,4-d]pyriniidin-1-y1]-1-piperidinvl]-2-propen-1-one and its polymorphs thereof